Innovation, Technology, and IP News
"Thrombosis" contest online
Patexia's latest licensing search features an invention that reduces stent thrombosis.
Apple Earnings -- still hand-over-fist
Apple's quarterly earnings report came out better than some anticipated, reports Businessweek. The company saw continued success with its latest iProducts, announcing $43.6 billion ...
NPE licensing and tech transfer
Proliferating NPEs are a recent manifestation of an IP industry shifting in the direction of licensing, and an indicator that tech transfer needs to catch up.
How to license a patent; Patent Knowledge Tidbits
Patent licensing is an increasingly prominent way of monetizing inventions.
Feed tagged as "drugs":
Scientists have developed a process that would make the most effective anti-malarial treatment less costly. The new technique makes it easier to produce artemisinin... Read More »
Cases in which a newly approved drug is more effective than the cheaper alternatives already available are the exceptions rather than the rule. This is the conclusion ... Read More »
Researchers at Brigham and Women’s Hospital in Boston, Mass. have developed a new mechanism of drug release. It uses 3D superhydrophobic materials that make use ... Read More »
Researchers have discovered a brain mechanism that limits the rewarding sensations of cocaine. Recent research with rodents implicated histone deacetylases (HDACs)... Read More »
Researchers at the University of Buffalo (UB) have released results indicating that ORMOSIL (organically modified silica) nanoparticles could be used to deliver... Read More »
Bioengineers at Tufts University School of Engineering have developed a silk-based microneedle able to deliver precise drug amounts over a set time. In addition... Read More »
Researchers at Children’s Hospital Boston have created a new mathematical model that combines multiple forms of widely available data to predict adverse drug... Read More »
McKesson High Volume Solutions will introduce ExpressRx Track this week in New Orleans at the 46th American Society of Health-system Pharmacists Midyear Clinical... Read More »
BRUSSELS (Reuters) - Belgian biotech firm Ablynx said on Friday that it had regained the rights for its TNF-Alpha targeting nanobodies from Pfizer, which... Read More »
(Reuters) - U.S. health regulators approved on Friday the stroke preventer Xarelto from Bayer AG and Johnson & Johnson for people with a common heart rhythm... Read More »
Traditionally, drugs were discovered by identifying active ingredients in known remedies or through serendipitous discovery, such as penicillin. Currently, drug... Read More »
By Toni Clarke
(Reuters) - Biogen Idec Inc's said on Wednesday its experimental... Read More »
GENEVA (Reuters) - The World Intellectual Property Organization launched a consortium on Wednesday that would allow the public and private sector to... Read More »
LONDON (Reuters) - Two lung drugs being developed by Novartis and its British partner Vectura face delays in the United States, the... Read More »
(Reuters) - Exelixis Inc's drug to treat a rare form of thyroid cancer met the main goal of a late-stage study, prompting the company to look to an... Read More »
Follow Patexia.
